Grey Cloak Tech Inc. (GRCK)

Our latest clients all have the potential to grow significantly in the near and long-term future

Grey Cloak Tech Inc. (GRCK)

Postby QualityStocks » Mon Oct 23, 2017 3:15 pm

Grey Cloak Tech Inc. (OTCQB: GRCK), a Las Vegas, Nevada-based company, targets the rapidly growing cannabinoid (CBD) market through its wholly owned subsidiary Eqova Life Sciences, which focuses on providing a full spectrum line of clinical-grade hemp oil (CBD) products to the medical practitioner market. Eqova Life Sciences develops its own high quality, branded product line of hemp oil health products, with the offer of producing private labels to qualified partners.

Eqova Life Sciences recently exhibited the company’s CBD products at the Integrative Medicine Summit in Denver, Colorado, which was attended by over 200 medical professionals. As part of the exhibition, Eqova Life Sciences also debuted its new CannaBio Salve, an innovative topical salve infused with several aromatic natural oils. The company’s formulations combine the scientifically-validated, powerful benefits of cannabinoids in standardized products which are then distributed to patients under the care of qualified health practitioners. All Eqova products are carefully researched and go through rigorous third-party testing before and after marketing, providing the security of a clinical-grade product made in cGMP Compliant Labs located in the United States.

According to The Hemp Business Journal, the CBD products marketplace is projected to grow 700 percent by 2020 with annual sales reaching $2.1 billion. The recent purchase of Eqova Life Sciences is a natural fit for the company since it has been looking for a way to build shareholder value by adding acquisitions from the rapidly growing CBD sector. Grey Cloak Tech believes medical practitioners seeking high-quality CBD products represent a vastly underserved market. To date, no other hemp oil company has exclusively focused on providing clinical-grade, full-spectrum hemp oil products to this important segment of the medical community.

Grey Cloak Tech also develops advanced software to overcome costly digital threats, most commonly known as online fraud. Grey Cloak Tech leads the industry with continuous development of the most comprehensive and effective weapons against online security threats. The company’s proprietary digital advertising fraud detection software, Fraudlytic, provides a cloud-based, secure platform that monitors Internet traffic in real time, blocking malicious and false clicks, while allowing real consumers to view offers and make purchases.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1123
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Grey Cloak Tech Inc. (GRCK)

Postby QualityStocks » Tue Oct 24, 2017 5:43 pm

Grey Cloak Tech Inc. (GRCK) is “One to Watch”

- Eqova Life Sciences subsidiary serves underserved market in booming CBD sector
- Clinical-grade, full-spectrum hemp oil products specifically produced for licensed medical use
- CBD market expected to grow 700% to $2.1 billion by 2020

Grey Cloak Tech Inc. (OTCQB: GRCK), a Las Vegas, Nevada-based company, targets the rapidly growing cannabinoid (CBD) market through its wholly owned subsidiary Eqova Life Sciences, which focuses on providing a full spectrum line of clinical-grade hemp oil (CBD) products to the medical practitioner market. Eqova Life Sciences develops its own high quality, branded product line of hemp oil health products, with the offer of producing private labels to qualified partners.

Eqova Life Sciences recently exhibited the company’s CBD products at the Integrative Medicine Summit in Denver, Colorado, which was attended by over 200 medical professionals. As part of the exhibition, Eqova Life Sciences also debuted its new CannaBio Salve, an innovative topical salve infused with several aromatic natural oils. The company’s formulations combine the scientifically-validated, powerful benefits of cannabinoids in standardized products which are then distributed to patients under the care of qualified health practitioners. All Eqova products are carefully researched and go through rigorous third-party testing before and after marketing, providing the security of a clinical-grade product made in cGMP Compliant Labs located in the United States.

According to The Hemp Business Journal, the CBD products marketplace is projected to grow 700 percent by 2020 with annual sales reaching $2.1 billion. The recent purchase of Eqova Life Sciences is a natural fit for the company since it has been looking for a way to build shareholder value by adding acquisitions from the rapidly growing CBD sector. Grey Cloak Tech believes medical practitioners seeking high-quality CBD products represent a vastly underserved market. To date, no other hemp oil company has exclusively focused on providing clinical-grade, full-spectrum hemp oil products to this important segment of the medical community.

Grey Cloak Tech also develops advanced software to overcome costly digital threats, most commonly known as online fraud. Grey Cloak Tech leads the industry with continuous development of the most comprehensive and effective weapons against online security threats. The company’s proprietary digital advertising fraud detection software, Fraudlytic, provides a cloud-based, secure platform that monitors Internet traffic in real time, blocking malicious and false clicks, while allowing real consumers to view offers and make purchases.

For more information, visit the company’s website at www.GreyCloakTech.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1123
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Grey Cloak Tech Inc. (GRCK)

Postby QualityStocks » Wed Oct 25, 2017 3:33 am

NetworkNewsBreaks – Grey Cloak Tech, Inc. (GRCK) Acquires Eqova Life Sciences

Grey Cloak Tech, Inc. (OTCQB: GRCK) this morning announced that it has acquired Eqova Life Sciences, a medically-focused CBD company, in an all-stock transaction. Located in Denver, Colorado, Eqova Life Sciences develops clinical-grade Full Spectrum Hemp Oil products that are sold exclusively via partnerships with licensed medical practitioners. Per the news release, no other hemp oil company currently focuses exclusively on the practitioner market, leaving it largely underserved. Included in the acquisition, Eqova has approximately $150,000 worth of CBD inventory, which is expected to be sold by the end of 2017. Eqova also has hundreds of relationships with suppliers, vendors and medical professionals who can carry their products and dozens of independent sales reps, as well as thousands in sales ready to book to Grey Cloak’s income statement. “Now that we have merged with GRCK, the possibilities for us in the CBD space are endless,” Patrick Stiles, incoming president and CEO of Grey Cloak, stated in the news release. “Eqova will just be the beginning. We will have the flexibility to enter many other segments of the industry.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1123
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Grey Cloak Tech Inc. (GRCK)

Postby QualityStocks » Thu Oct 26, 2017 6:21 pm

NetworkNewsBreaks – Grey Cloak Tech, Inc. (GRCK) Announces Cancellation of Reverse Stock Split

Grey Cloak Tech, Inc. (OTCQB: GRCK) today announced that its board of directors has decided to abandon and cancel the reverse stock split that was previously approved by both the board and the company’s shareholders in February 2017. Per the update, the board believes that, given the company’s recent acquisition and changes in the market since the time of the approval, it is in the best interest of Grey Cloak Tech to cancel the reverse split. Today’s announcement comes just two days after Grey Cloak Tech announced its acquisition of medically-focused CBD company Eqova Life Sciences in an all-stock transaction.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1123
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Grey Cloak Tech Inc. (GRCK)

Postby QualityStocks » Tue Oct 31, 2017 4:36 pm

Strategic Acquisition Enables Grey Cloak Tech, Inc.’s (GRCK) Development in Two Industries

- Through its acquisition of Eqova Life Sciences, Grey Cloak has successfully entered the CBD oil industry
- At the same time, the company remains focused on furthering the effectiveness of its digital advertising fraud prevention software
- Both the CBD oil and the digital marketing fraud prevention markets are expected to grow exponentially throughout 2018

On October 24, 2017, Grey Cloak Tech, Inc. (OTCQB: GRCK) announced a 100 percent acquisition of Eqova Life Sciences – a renowned manufacturer of a wide range of hemp oil products. The company sent a letter of intent pertaining to the acquisition in September. Eqova, a company located in Denver, develops clinical-grade full spectrum hemp oil products and it distributes via partnerships with licensed medical practitioners.

According to official reports, Eqova has CBD inventory worth approximately 150,000 dollars in retail value. Grey Cloak announced that the inventory will be sold by the end of 2017. The company’s extensive partnership network is the one factor that will contribute to the fast completion of commercial transactions.

The strategic acquisition of a medically-focused CBD company comes at a time of exponential market growth. The Hemp Business Journal reports that the CBD marketplace is expected to experience growth of 700 percent by 2020 (http://nnw.fm/O9Ajo). This means that the sales volume by that year will be 2.1 billion dollars.

Another report by the Brightfield Group suggests that massive growth can be expected in as little as three years. The report presented by Forbes states that CBD sales reached 170 million dollars in 2016 (http://nnw.fm/1Qbz4). The compound annual growth rate is 55 percent, which means that the billion-dollar mark will be breached in less than five years.

Eqova’s acquisition enables the hi-tech company to begin its rapid evolution in a completely new industry. Until the completion of the Eqova deal, Grey Cloak primarily specialized in the development of anti-fraud digital solutions. Founded in 2004 and operating from Las Vegas, Nevada, the software technology company develops cloud-based solutions for the purpose of detecting and preventing advertising fraud (click fraud, for example). As of December 2016, the company has a total revenue of 162.75 thousand dollars and a gross profit of 135.817 thousand dollars.

Most of the profit generated in 2016 occurred through the sale of Fraudlytic, Grey Cloak Tech’s debut product. The solution is aimed at addressing the needs of key clients across multiple commercial fields. It was developed to reduce the risk of digital advertising fraud – a prominent threat that many companies engaged in the execution of inbound marketing campaigns face.

According to the Interactive Advertising Bureau, the so-called click fraud could be costing advertisers 8.2 billion dollars per year (http://nnw.fm/Q4Lab). The cost of click fraud is projected to become much higher in the future – 50 billion dollars by 2020, the World Federation of Advertisers reported (http://nnw.fm/5IXm9).

An official corporate announcement states that Grey Cloak Tech will continue its involvement in the cloud-based software field after the acquisition of Eqova and its new development within the CBD market. The company launched Fraudlytic 2.0 in August 2016 and performance updates are being rolled out all the time.

For more information, visit the company’s website at www.GreyCloakTech.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1123
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Grey Cloak Tech Inc. (GRCK)

Postby QualityStocks » Thu Nov 02, 2017 5:06 pm

NetworkNewsBreaks – Grey Cloak Tech, Inc. (GRCK) Enters CBD Market through Strategic Acquisition

Grey Cloak Tech, Inc. (OTCQB: GRCK) recently entered the booming cannabis industry through the strategic acquisition of a medically-focused CBD company, Eqova Life Sciences. An article discussing this reads: “On October 24, 2017, Grey Cloak Tech, Inc. (OTCQB: GRCK) announced a 100 percent acquisition of Eqova Life Sciences – a renowned manufacturer of a wide range of hemp oil products. The company sent a letter of intent pertaining to the acquisition in September. Eqova, a company located in Denver, develops clinical-grade full spectrum hemp oil products, and it distributes via partnerships with licensed medical practitioners.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1123
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Grey Cloak Tech Inc. (GRCK)

Postby QualityStocks » Wed Nov 08, 2017 6:11 pm

Grey Cloak Tech, Inc. (GRCK) to Debut CannaBio Salve in Las Vegas at MJBizCon, November 14-17, through Subsidiary Eqova Life Sciences

- Clinical-grade salve is designed for topical skin use and contains full spectrum hemp oil, menthol, and essential oils; it is developed to treat minor skin irritations and tight or sore muscles
- Eqova will distribute salve to patients through licensed health practitioners
- Marijuana Business Conference (MJBizCon) is the industry’s premier and largest trade show, generating for Eqova an audience of potentially thousands of cannabis-related executives

Grey Cloak Tech, Inc. (OTCQB: GRCK), through subsidiary Eqova Life Sciences, will introduce CannaBio Salve at the Marijuana Business Conference (MJBizCon), to be held November 14-17 in Las Vegas (http://nnw.fm/nX3w4). Per the announcement, it is the industry’s premier cannabis trade show. CannaBio Salve is a topical skin product containing full spectrum hemp oil, menthol and essential oils.

The salve is designed to treat minor skin irritations and tight or sore muscles. It is Eqova’s second product developed for topical skin use.

GRCK acquired 100% of Eqova in an all-stock transaction last month. Eqova offers clinical-grade products manufactured in cGMP-compliant labs located in the United States. It is focused on the medical practitioner market, offering products that are carefully researched and tested by third-parties before and after marketing. These products use full-spectrum hemp oil plus other ingredients to achieve standardized dosing. Distribution to patients is achieved through licensed health practitioners, as noted on Eqova’s website.

In today’s news release, Matthew Grabau, Eqova Life Sciences co-founder and CMO, said, “We’re very excited about introducing CannaBio Salve. There has been a lot of interest from our practitioners in the product already. We’ve been taking pre-sales for the product for quite some time, and we fully expect it to be one of top two sellers.”

Eqova’s management team will be at MJBizCon in Las Vegas to introduce CannaBio Salve, as well as the rest of the company’s line. At this trade show, Eqova’s products will be seen by potentially thousands of cannabis-related executives.

For more information, visit the company’s website at www.GreyCloakTech.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1123
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Grey Cloak Tech Inc. (GRCK)

Postby QualityStocks » Thu Nov 09, 2017 7:23 pm

NetworkNewsBreaks – Grey Cloak Tech, Inc.’s (GRCK) Subsidiary Eqova Products to be Presented at MJBizCon

In an all-stock transaction last month, Grey Cloak Tech, Inc. (OTCQB: GRCK) acquired 100% of Eqova Life Sciences. The company is attending a conference in Las Vegas where Eqova’s products will be seen by potentially thousands of cannabis-related executives. An article discussing this reads: “Grey Cloak Tech, Inc. (OTCQB: GRCK), through subsidiary Eqova Life Sciences, will introduce CannaBio Salve at the Marijuana Business Conference (MJBizCon), to be held November 14-17 in Las Vegas (http://nnw.fm/nX3w4). Per the announcement, it is the industry’s premier cannabis trade show. CannaBio Salve is a topical skin product containing full spectrum hemp oil, menthol and essential oils.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1123
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Grey Cloak Tech Inc. (GRCK)

Postby QualityStocks » Wed Nov 15, 2017 6:35 pm

NetworkNewsBreaks – Grey Cloak Tech, Inc. (GRCK) Aims to Create CBD Marketplace with Purchase of CBD.co Domain

Grey Cloak Tech (OTCQB: GRCK) announced today that is has purchased the domain CBD.co. with an objective to create a media destination and primary marketplace for all types of hemp products, with a particular focus on cannabidiol (“CBD”) products. The company intends to make CBD.co the solution to a large division in the market, as major advertising companies currently do not allow CBD products on their platforms. CBD.co aspires to become the centralized, third-party marketplace available for producers and consumers of hemp products.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1123
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Grey Cloak Tech Inc. (GRCK)

Postby QualityStocks » Tue Nov 28, 2017 6:34 pm

NetworkNewsBreaks – Grey Cloak Tech (GRCK) Names Chief Marketing Officer for New Website

Grey Cloak Tech Inc. (OTCQB: GRCK) this morning announced its hiring of Steve Goldberg to handle web traffic growth for the company’s new online site, CBD.co, bringing to bear years of experience with search engine optimization and conversion rate optimization. "I'm incredibly excited about this project. Initially I was looking at taking on CBD.co as a part time client, however after attending the MJ BizCon conference in Las Vegas with the Grey Cloak management team and seeing the success they had first hand, I immediately wanted to expand my role,” Goldberg stated in a news release about his new role.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1123
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Grey Cloak Tech Inc. (GRCK)

Postby QualityStocks » Fri Dec 08, 2017 8:31 pm

NetworkNewsBreaks – Grey Cloak Tech Inc. (GRCK) Targets Massive CBD Market Through Eqova Life Sciences Subsidiary

Grey Cloak Tech (OTCQB: GRCK) is positioning itself to profit from the growing cannabinoid (“CBD”) market through its wholly owned subsidiary Eqova Life Sciences. An article discussing this reads: “Eqova Life Sciences recently exhibited the company’s CBD products at the Integrative Medicine Summit in Denver, Colorado, which was attended by over 200 medical professionals. As part of the exhibition, Eqova Life Sciences also debuted its new CannaBio Salve, an innovative topical salve infused with several aromatic natural oils. The company’s formulations combine the scientifically-validated, powerful benefits of cannabinoids in standardized products which are then distributed to patients under the care of qualified health practitioners. All Eqova products are carefully researched and go through rigorous third-party testing before and after marketing, providing the security of a clinical-grade product made in cGMP Compliant Labs located in the United States.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 1123
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ


Return to QualityStocks Featured Companies

Who is online

Users browsing this forum: No registered users and 4 guests